Home › APNewsBreak: NY bid to halt Alzheimer's drug swap
 

Keywords :   


APNewsBreak: NY bid to halt Alzheimer's drug swap

2014-09-16 02:32:11| Biotech - Topix.net

New York's attorney general filed a federal lawsuit Monday seeking to stop a manufacturer from discontinuing its drug widely used to treat Alzheimer's patients, arguing the company is illegally driving patients to its newer patented drug to avoid losses from cheaper generic alternatives coming out next year. Attorney General Eric Schneiderman alleges anti-trust and state law violations by Dublin-based Actavis PLC and New York subsidiary Forest Laboratories, which Actavis recently acquired for $28 billion.

Tags: drug bid halt swap

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
20.09Atlantic Tropical Weather Outlook
20.09Eastern North Pacific Tropical Weather Outlook
20.09This weeks lesson: Weaning matters in the cattle market
20.09Construction giant collapses putting 2,400 jobs at risk
20.09KANSAI HELIOS Further Expands as System Supplier in Italy
20.09Colorado Rancher named PLC president as annual meeting closes
20.09New Acrylic Resin for Architectural Coatings Without Fluorosurfactants from EPS
20.09¦nie¿ka Publishes Results for 1H 2024
More »